首页 > 最新文献

Congenital Anomalies最新文献

英文 中文
Accumulation of ether phospholipids in induced pluripotent stem cells and oligodendrocyte-lineage cells established from patients with Sjögren-Larsson syndrome 来自Sjögren-Larsson综合征患者的诱导多能干细胞和少突胶质细胞系细胞中乙醚磷脂的积累
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2024-12-01 DOI: 10.1111/cga.12587
Yu Yamaguchi, Hironobu Okuno, Suzumi Tokuoka, Yoshihiro Kita, Tsukasa Sanosaka, Jun Kohyama, Kenji Kurosawa, Norio Sakai, Fuyuki Miya, Takao Takahashi, Kenjiro Kosaki, Hideyuki Okano

Sjögren-Larsson syndrome (SLS) is an autosomal recessive leukodystrophy characterized by ichthyosis, intellectual disability, and progressive spastic paralysis caused by biallelic pathogenic variants in the ALDH3A2 gene that encodes the fatty aldehyde dehydrogenase, fatty aldehyde dehydrogenase (FALDH); FALDH catalyzes several metabolic reactions involved in fatty aldehyde oxidation. Only a few studies have been performed to determine the lipid profile of patients with SLS. In a previous postmortem study of the brain of a 65-year-old patient with SLS, lipidomic analysis revealed an accumulation of long-chain unsaturated ether lipid species in the white matter and gray matter. In the present study, we established a disease model using patient-derived neuronal and oligodendrocyte lineage cells to analyze the lipid metabolism and gene expression profiles in SLS. To achieve this, we generated induced pluripotent stem cells (iPSCs) from two patients with the SLS phenotype carrying previously known ALDH3A2 pathogenic variants: One was a compound heterozygote (c.1339A>G:p.(Lys447Glu) and c.57_132dup:p.(Ile45Serfs*34)) and the other was a homozygote (c.1339A>G: p.(Lys447Glu)). The FALDH activity was almost zero in the SLS-iPSC lines established from both patients. Phospholipid analysis of neurospheres, and oligospheres (spheres enriched with oligodendrocyte-lineage cells) derived from the iPSCs by liquid chromatography-mass spectrometry showed accumulation of ether phospholipids in the Sjögren-Larsson patient-derived neurospheres and oligospheres. The results are consistent with the previously reported accumulation of ether lipids in the postmortem brain tissue of an SLS patient. Therefore, iPSCs and iPSC-derived neurospheres and oligospheres established from SLS patients can be useful tools for future pathological analysis of the central nervous system pathophysiology in SLS.

Sjögren-Larsson综合征(SLS)是一种常染色体隐性白质营养不良症,以鱼鱼病、智力残疾和进行性痉挛性瘫痪为特征,由编码脂肪醛脱氢酶、脂肪醛脱氢酶(FALDH)的ALDH3A2基因的双等位致病变异引起;FALDH催化脂肪醛氧化的几种代谢反应。只有少数研究被用于确定SLS患者的脂质谱。在之前对一名65岁SLS患者的大脑进行的尸检研究中,脂质组学分析显示,长链不饱和醚类脂质在白质和灰质中积累。在本研究中,我们利用患者来源的神经元和少突胶质细胞谱系细胞建立了疾病模型,分析了SLS的脂质代谢和基因表达谱。为了实现这一目标,我们从两个携带已知ALDH3A2致病变异的SLS表型患者中产生了诱导多能干细胞(iPSCs):一个是复合杂合子(c.1339A>G:p.(Lys447Glu)和c.57_132dup:p.(Ile45Serfs*34)),另一个是纯合子(c.1339A>G:p.(Lys447Glu))。在两名患者建立的SLS-iPSC系中,FALDH活性几乎为零。通过液相色谱-质谱法对来自iPSCs的神经球和寡球(富含少突胶质细胞谱系细胞的球)进行磷脂分析,发现Sjögren-Larsson患者来源的神经球和寡球中有醚磷脂的积累。该结果与先前报道的SLS患者死后脑组织中乙醚脂质积累一致。因此,从SLS患者身上建立的iPSCs及其衍生的神经球和寡球可以成为未来SLS患者中枢神经系统病理生理病理分析的有用工具。
{"title":"Accumulation of ether phospholipids in induced pluripotent stem cells and oligodendrocyte-lineage cells established from patients with Sjögren-Larsson syndrome","authors":"Yu Yamaguchi,&nbsp;Hironobu Okuno,&nbsp;Suzumi Tokuoka,&nbsp;Yoshihiro Kita,&nbsp;Tsukasa Sanosaka,&nbsp;Jun Kohyama,&nbsp;Kenji Kurosawa,&nbsp;Norio Sakai,&nbsp;Fuyuki Miya,&nbsp;Takao Takahashi,&nbsp;Kenjiro Kosaki,&nbsp;Hideyuki Okano","doi":"10.1111/cga.12587","DOIUrl":"https://doi.org/10.1111/cga.12587","url":null,"abstract":"<p>Sjögren-Larsson syndrome (SLS) is an autosomal recessive leukodystrophy characterized by ichthyosis, intellectual disability, and progressive spastic paralysis caused by biallelic pathogenic variants in the <i>ALDH3A2</i> gene that encodes the fatty aldehyde dehydrogenase, fatty aldehyde dehydrogenase (FALDH); FALDH catalyzes several metabolic reactions involved in fatty aldehyde oxidation. Only a few studies have been performed to determine the lipid profile of patients with SLS. In a previous postmortem study of the brain of a 65-year-old patient with SLS, lipidomic analysis revealed an accumulation of long-chain unsaturated ether lipid species in the white matter and gray matter. In the present study, we established a disease model using patient-derived neuronal and oligodendrocyte lineage cells to analyze the lipid metabolism and gene expression profiles in SLS. To achieve this, we generated induced pluripotent stem cells (iPSCs) from two patients with the SLS phenotype carrying previously known <i>ALDH3A2</i> pathogenic variants: One was a compound heterozygote (c.1339A&gt;G:p.(Lys447Glu) and c.57_132dup:p.(Ile45Serfs*34)) and the other was a homozygote (c.1339A&gt;G: p.(Lys447Glu)). The FALDH activity was almost zero in the SLS-iPSC lines established from both patients. Phospholipid analysis of neurospheres, and oligospheres (spheres enriched with oligodendrocyte-lineage cells) derived from the iPSCs by liquid chromatography-mass spectrometry showed accumulation of ether phospholipids in the Sjögren-Larsson patient-derived neurospheres and oligospheres. The results are consistent with the previously reported accumulation of ether lipids in the postmortem brain tissue of an SLS patient. Therefore, iPSCs and iPSC-derived neurospheres and oligospheres established from SLS patients can be useful tools for future pathological analysis of the central nervous system pathophysiology in SLS.</p>","PeriodicalId":10626,"journal":{"name":"Congenital Anomalies","volume":"65 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cga.12587","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142762304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan 日本妊娠早期使用头孢地酮酯安全性的系列案例研究
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2024-12-01 DOI: 10.1111/cga.12588
Mariko Honma, Naoto Suzuki, Mikako Goto, Taku Obara, Yoshiyuki Saito, Ken Nakajima, Ritsuko Yamane, Kunihiko Takahashi, Takeo Nakayama, Masahiro Hayashi, Atsuko Murashima, Akira Toyama

We evaluated the teratogenic risk associated with exposure to cefditoren pivoxil during the first trimester of pregnancy using the integrated databases of the Toranomon Hospital and the National Center for Child Health and Development. Among 13 599 registered individuals, the analysis included 285 subjects who had taken cefditoren pivoxil during the first trimester of pregnancy. The rates of stillbirth, miscarriage, and elective terminations were 0.4%, 5.6%, and 2.1%, respectively. Among 262 live births, the rates of preterm birth, low birth weight, and major congenital malformations were 4.6%, 5.7%, and 1.2%, respectively. Our results suggest that exposure to cefditoren pivoxil during the first trimester of pregnancy does not significantly increase the risk of adverse pregnancy outcomes and infant outcomes.

我们利用Toranomon医院和国家儿童健康与发展中心的综合数据库,评估了妊娠前三个月暴露于头孢地托伦酯的致畸风险。在13599名登记的个体中,分析包括285名在怀孕前三个月服用头孢地托林酯的受试者。死产、流产和选择性终止妊娠的发生率分别为0.4%、5.6%和2.1%。262例活产婴儿中,早产率为4.6%,低出生体重率为5.7%,重大先天性畸形率为1.2%。我们的研究结果表明,在怀孕的前三个月接触头孢地托伦酯不会显著增加不良妊娠结局和婴儿结局的风险。
{"title":"A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan","authors":"Mariko Honma,&nbsp;Naoto Suzuki,&nbsp;Mikako Goto,&nbsp;Taku Obara,&nbsp;Yoshiyuki Saito,&nbsp;Ken Nakajima,&nbsp;Ritsuko Yamane,&nbsp;Kunihiko Takahashi,&nbsp;Takeo Nakayama,&nbsp;Masahiro Hayashi,&nbsp;Atsuko Murashima,&nbsp;Akira Toyama","doi":"10.1111/cga.12588","DOIUrl":"https://doi.org/10.1111/cga.12588","url":null,"abstract":"<p>We evaluated the teratogenic risk associated with exposure to cefditoren pivoxil during the first trimester of pregnancy using the integrated databases of the Toranomon Hospital and the National Center for Child Health and Development. Among 13 599 registered individuals, the analysis included 285 subjects who had taken cefditoren pivoxil during the first trimester of pregnancy. The rates of stillbirth, miscarriage, and elective terminations were 0.4%, 5.6%, and 2.1%, respectively. Among 262 live births, the rates of preterm birth, low birth weight, and major congenital malformations were 4.6%, 5.7%, and 1.2%, respectively. Our results suggest that exposure to cefditoren pivoxil during the first trimester of pregnancy does not significantly increase the risk of adverse pregnancy outcomes and infant outcomes.</p>","PeriodicalId":10626,"journal":{"name":"Congenital Anomalies","volume":"65 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142762432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feelings and thoughts about life selection in pregnant women undergoing non-invasive prenatal testing in Japan 日本接受无创产前检测的孕妇对生命选择的感受和想法。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2024-11-25 DOI: 10.1111/cga.12586
Eri Takeda, Nobuhiro Suzumori, Kyoko Kumagai, Chisato Komata, Yumiko Nishimura, Mayumi Sugiura-Ogasawara

The objective of this study was to conduct qualitative research by clarifying the thoughts of pregnant women undergoing non-invasive prenatal testing (NIPT) in Japan, to collect evidence to provide information and psychosocial support in genetic counseling (GC). We attempted to conduct qualitative research to provide support for GC and the society in relation to children with special needs, by clarifying the thoughts of pregnant women undergoing NIPT. Between January 2016 and December 2017, we administered an open-ended questionnaire to pregnant Japanese women undergoing NIPT to clarify their ethical views in relation to children with special needs. The target population included 754 pregnant women who described their feelings and thoughts about undergoing NIPT and about children with special needs. Pregnant women undergoing NIPT have a variety of various mixed feelings and concerns. We classified the feelings and thoughts of pregnant women who underwent NIPT into the following four primary categories (multiple classifications): (1) perception about people with special needs (18.0%); (2) relation between NIPT and life selection (22.3%); (3) attitudes towards undergoing NIPT (47.5%); and (4) negative feelings and thoughts about raising children with special needs (48.1%). Most pregnant women undergoing NIPT expressed negative feelings and raising children with special needs. These feelings and thoughts may be one of the reasons why pregnant women undergo NIPT. In GC, it is important to also provide wide information on the social support and the current situation in the actual life of children with special needs.

本研究旨在通过澄清日本接受无创产前检测(NIPT)的孕妇的想法来开展定性研究,从而收集证据,为遗传咨询(GC)提供信息和社会心理支持。我们试图通过澄清接受无创产前检测的孕妇的想法,开展定性研究,为遗传咨询和社会提供与有特殊需求儿童相关的支持。2016年1月至2017年12月期间,我们对接受NIPT的日本孕妇进行了开放式问卷调查,以澄清她们对特殊儿童的伦理看法。目标人群包括 754 名孕妇,她们描述了自己对接受 NIPT 和有特殊需求儿童的感受和想法。接受 NIPT 的孕妇有各种不同的感受和担忧。我们将接受 NIPT 的孕妇的感受和想法分为以下四个主要类别(多种分类):(1)对有特殊需要人群的看法(18.0%);(2)NIPT 与生命选择的关系(22.3%);(3)对接受 NIPT 的态度(47.5%);(4)对抚养有特殊需要儿童的负面感受和想法(48.1%)。大多数接受 NIPT 的孕妇对养育有特殊需要的儿童有负面的感受和想法。这些感受和想法可能是孕妇接受 NIPT 的原因之一。在 GC 中,提供有关社会支持和有特殊需要儿童实际生活现状的广泛信息也很重要。
{"title":"Feelings and thoughts about life selection in pregnant women undergoing non-invasive prenatal testing in Japan","authors":"Eri Takeda,&nbsp;Nobuhiro Suzumori,&nbsp;Kyoko Kumagai,&nbsp;Chisato Komata,&nbsp;Yumiko Nishimura,&nbsp;Mayumi Sugiura-Ogasawara","doi":"10.1111/cga.12586","DOIUrl":"10.1111/cga.12586","url":null,"abstract":"<p>The objective of this study was to conduct qualitative research by clarifying the thoughts of pregnant women undergoing non-invasive prenatal testing (NIPT) in Japan, to collect evidence to provide information and psychosocial support in genetic counseling (GC). We attempted to conduct qualitative research to provide support for GC and the society in relation to children with special needs, by clarifying the thoughts of pregnant women undergoing NIPT. Between January 2016 and December 2017, we administered an open-ended questionnaire to pregnant Japanese women undergoing NIPT to clarify their ethical views in relation to children with special needs. The target population included 754 pregnant women who described their feelings and thoughts about undergoing NIPT and about children with special needs. Pregnant women undergoing NIPT have a variety of various mixed feelings and concerns. We classified the feelings and thoughts of pregnant women who underwent NIPT into the following four primary categories (multiple classifications): (1) perception about people with special needs (18.0%); (2) relation between NIPT and life selection (22.3%); (3) attitudes towards undergoing NIPT (47.5%); and (4) negative feelings and thoughts about raising children with special needs (48.1%). Most pregnant women undergoing NIPT expressed negative feelings and raising children with special needs. These feelings and thoughts may be one of the reasons why pregnant women undergo NIPT. In GC, it is important to also provide wide information on the social support and the current situation in the actual life of children with special needs.</p>","PeriodicalId":10626,"journal":{"name":"Congenital Anomalies","volume":"65 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142717167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acknowledgement 鸣谢
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2024-11-03 DOI: 10.1111/cga.12585
{"title":"Acknowledgement","authors":"","doi":"10.1111/cga.12585","DOIUrl":"https://doi.org/10.1111/cga.12585","url":null,"abstract":"","PeriodicalId":10626,"journal":{"name":"Congenital Anomalies","volume":"64 6","pages":"260"},"PeriodicalIF":1.3,"publicationDate":"2024-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142579781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acoustic evaluation of voice signal distortion by videoconferencing platforms and devices used in telepractice for cleft palate 对腭裂远程治疗中使用的视频会议平台和设备造成的语音信号失真进行声学评估。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2024-10-08 DOI: 10.1111/cga.12584
Shiho Tajiri, Shunsuke Hidaka, Shuhei Takehisa, Sachiyo Hasegawa, Yukiko Ohyama, Tomohiro Yamada

The usefulness and effectiveness of telepractice have been reported in recent years. Treatment of cleft palate patients with compensatory articulation is based on perceptual identification. Telepractice using videoconferencing platforms causes voice signal distortion and impacts auditory-perceptual perception. This study aimed acoustically examine voice signal distortion and determine the optimal videoconferencing platforms, in addition to the phonemes that can be discriminated with the same quality as in face-to-face interactions. ATR503 with 50 phoneme-balanced Japanese speech sentences was used as a reference corpus. Four videoconferencing platforms, —Zoom, Cisco Webex, Skype, and Google Meet, —and five devices, —iPhone, Android, iPad Air, Windows, and MacBook Pro were used as transmission conditions to examine voice signal distortions with the objective measure log-spectral distortion (LSD). Tukey's test was conducted to evaluate the degree of consonant distortion related to voicings (voiceless and voiced), places of articulation (bilabial, alveolar, alveolo-palatal, palatal, velar, labial-velar, and glottal), and manners of articulation (plosive, fricative, affricate, tap or flap, nasal, and approximant). With statistically significant differences, voiced, bilabial, labial-velar, nasal, and plosive consonants exhibited smaller distortions. In contrast, voiceless, alveolo-palatal, fricative, and affricate consonants exhibited larger distortions. Google Meet exhibited the lowest distortion among videoconferencing platforms and MacBook exhibited the lowest distortion among devices. This study provides significant insights into the telepractice strategies with the appropriate videoconferencing platform and device, and useful settings for cleft palate patients with compensatory articulations with respect to acoustics.

近年来,关于远程练习的实用性和有效性已有报道。对腭裂患者的补偿发音治疗是以感知识别为基础的。使用视频会议平台进行远程练习会导致语音信号失真,影响听觉感知。本研究旨在从声学角度检查语音信号失真,并确定最佳视频会议平台,以及能辨别出与面对面交流质量相同的音素。ATR503 包含 50 个音素平衡的日语语音句子,被用作参考语料库。将四种视频会议平台(Zoom、Cisco Webex、Skype 和 Google Meet)和五种设备(iPhone、Android、iPad Air、Windows 和 MacBook Pro)作为传输条件,用对数频谱失真(LSD)这一客观指标来检测语音信号失真。采用 Tukey's 检验来评估辅音失真程度与发声(无声和有声)、发音部位(双唇、齿龈、齿龈-腭、腭、天鹅绒、唇-声门和喉音)和发音方式(塞音、摩擦音、副元音、拍音或瓣音、鼻音和近似音)的关系。在统计上有显著差异的是,声母、双唇辅音、唇瓣辅音、鼻音辅音和犁音辅音的失真较小。相比之下,无嗓辅音、齿龈腭辅音、擦音辅音和塞音辅音的失真较大。在视频会议平台中,Google Meet 的失真最小,而在设备中,MacBook 的失真最小。这项研究为使用合适的视频会议平台和设备进行远程练习的策略提供了重要启示,并为具有声学补偿发音的腭裂患者提供了有用的设置。
{"title":"Acoustic evaluation of voice signal distortion by videoconferencing platforms and devices used in telepractice for cleft palate","authors":"Shiho Tajiri,&nbsp;Shunsuke Hidaka,&nbsp;Shuhei Takehisa,&nbsp;Sachiyo Hasegawa,&nbsp;Yukiko Ohyama,&nbsp;Tomohiro Yamada","doi":"10.1111/cga.12584","DOIUrl":"10.1111/cga.12584","url":null,"abstract":"<p>The usefulness and effectiveness of telepractice have been reported in recent years. Treatment of cleft palate patients with compensatory articulation is based on perceptual identification. Telepractice using videoconferencing platforms causes voice signal distortion and impacts auditory-perceptual perception. This study aimed acoustically examine voice signal distortion and determine the optimal videoconferencing platforms, in addition to the phonemes that can be discriminated with the same quality as in face-to-face interactions. ATR503 with 50 phoneme-balanced Japanese speech sentences was used as a reference corpus. Four videoconferencing platforms, —Zoom, Cisco Webex, Skype, and Google Meet, —and five devices, —iPhone, Android, iPad Air, Windows, and MacBook Pro were used as transmission conditions to examine voice signal distortions with the objective measure log-spectral distortion (LSD). Tukey's test was conducted to evaluate the degree of consonant distortion related to voicings (voiceless and voiced), places of articulation (bilabial, alveolar, alveolo-palatal, palatal, velar, labial-velar, and glottal), and manners of articulation (plosive, fricative, affricate, tap or flap, nasal, and approximant). With statistically significant differences, voiced, bilabial, labial-velar, nasal, and plosive consonants exhibited smaller distortions. In contrast, voiceless, alveolo-palatal, fricative, and affricate consonants exhibited larger distortions. Google Meet exhibited the lowest distortion among videoconferencing platforms and MacBook exhibited the lowest distortion among devices. This study provides significant insights into the telepractice strategies with the appropriate videoconferencing platform and device, and useful settings for cleft palate patients with compensatory articulations with respect to acoustics.</p>","PeriodicalId":10626,"journal":{"name":"Congenital Anomalies","volume":"64 6","pages":"242-253"},"PeriodicalIF":1.3,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cga.12584","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genitourinary and craniofacial/cervicothoracic anomalies in a neonate with in-utero mycophenolate mofetil exposure 一名在子宫内接触过霉酚酸酯的新生儿出现泌尿生殖系统和颅面/颈胸椎异常。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2024-09-18 DOI: 10.1111/cga.12583
Sayu Omori-Shimano, Kazushige Ikeda, Jun Miyauchi, Maki Fukami
{"title":"Genitourinary and craniofacial/cervicothoracic anomalies in a neonate with in-utero mycophenolate mofetil exposure","authors":"Sayu Omori-Shimano,&nbsp;Kazushige Ikeda,&nbsp;Jun Miyauchi,&nbsp;Maki Fukami","doi":"10.1111/cga.12583","DOIUrl":"10.1111/cga.12583","url":null,"abstract":"","PeriodicalId":10626,"journal":{"name":"Congenital Anomalies","volume":"64 6","pages":"257-259"},"PeriodicalIF":1.3,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142303410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Congenital cytomegalovirus and pulmonary hypertension 先天性巨细胞病毒与肺动脉高压
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2024-09-04 DOI: 10.1111/cga.12580
Layah Alkoby-Meshulam, Jacob Amir, Daniel Lubin, Gil Klinger, Giora Guttesman, Samuel Zangen, Efraim Bilavsky

Lung involvement in children with congenital cytomegalovirus infection has been scarcely described. We describe three new cases of persistent pulmonary hypertension in children with congenital cytomegalovirus and review the other seven cases reported in the literature since 1988. All children had a symptomatic infection, including severe central nervous system or visceral findings. Morbidity and mortality were high. Persistent pulmonary hypertension may be a rare complication in severely symptomatic congenital cytomegalovirus infants. It is important to screen for congenital cytomegalovirus in cases of idiopathic refractory persistent pulmonary hypertension. Intensive treatment should be undertaken to treat this potentially rare lung involvement in combination with antiviral treatment.

关于先天性巨细胞病毒感染患儿肺部受累的描述很少。我们描述了三例先天性巨细胞病毒感染儿童持续性肺动脉高压的新病例,并回顾了自 1988 年以来文献中报道的其他七例病例。所有患儿均有感染症状,包括严重的中枢神经系统或内脏症状。发病率和死亡率都很高。在症状严重的先天性巨细胞病毒感染婴儿中,持续性肺动脉高压可能是一种罕见的并发症。对特发性难治性持续肺动脉高压病例进行先天性巨细胞病毒筛查非常重要。在进行抗病毒治疗的同时,应进行强化治疗,以治疗这种潜在的罕见肺部受累。
{"title":"Congenital cytomegalovirus and pulmonary hypertension","authors":"Layah Alkoby-Meshulam,&nbsp;Jacob Amir,&nbsp;Daniel Lubin,&nbsp;Gil Klinger,&nbsp;Giora Guttesman,&nbsp;Samuel Zangen,&nbsp;Efraim Bilavsky","doi":"10.1111/cga.12580","DOIUrl":"10.1111/cga.12580","url":null,"abstract":"<p>Lung involvement in children with congenital cytomegalovirus infection has been scarcely described. We describe three new cases of persistent pulmonary hypertension in children with congenital cytomegalovirus and review the other seven cases reported in the literature since 1988. All children had a symptomatic infection, including severe central nervous system or visceral findings. Morbidity and mortality were high. Persistent pulmonary hypertension may be a rare complication in severely symptomatic congenital cytomegalovirus infants. It is important to screen for congenital cytomegalovirus in cases of idiopathic refractory persistent pulmonary hypertension. Intensive treatment should be undertaken to treat this potentially rare lung involvement in combination with antiviral treatment.</p>","PeriodicalId":10626,"journal":{"name":"Congenital Anomalies","volume":"64 6","pages":"235-241"},"PeriodicalIF":1.3,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142127659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-progressive hepatic tumor with high levels of serum alpha-fetoprotein in two infants with trisomy 18 两名 18 三体综合征婴儿非进行性肝肿瘤伴高水平血清甲胎蛋白。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2024-08-29 DOI: 10.1111/cga.12582
Toshio Okamoto, Ken Nagaya, Mitsumaro Nii, Satoru Takahashi
{"title":"Non-progressive hepatic tumor with high levels of serum alpha-fetoprotein in two infants with trisomy 18","authors":"Toshio Okamoto,&nbsp;Ken Nagaya,&nbsp;Mitsumaro Nii,&nbsp;Satoru Takahashi","doi":"10.1111/cga.12582","DOIUrl":"10.1111/cga.12582","url":null,"abstract":"","PeriodicalId":10626,"journal":{"name":"Congenital Anomalies","volume":"64 6","pages":"254-256"},"PeriodicalIF":1.3,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142115998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Montelukast use in pregnancy: A systematic review and meta-analysis of maternal and fetal outcomes in asthma treatment 妊娠期使用孟鲁司特:对哮喘治疗中母体和胎儿结果的系统回顾和荟萃分析。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2024-08-11 DOI: 10.1111/cga.12581
Areeba Fareed, Dima Siblini, Rayyan Vaid, Hadi Farhat, Ahmad Rida, Abdulrahmon Moradeyo, Muhammad Ahsan Khan

This systematic review and meta-analysis evaluated the safety of montelukast in treating asthma during pregnancy, focusing on maternal and fetal outcomes such as congenital anomalies (CA), preterm delivery, low birthweight, spontaneous abortion, gestational diabetes mellitus, and preeclampsia. A comprehensive literature search was conducted in Google Scholar, PubMed, and the Cochrane Library databases from inception until April 30, 2024. The eligible studies assessed the safety of montelukast for asthma treatment during pregnancy. The review suggests that montelukast use during pregnancy may not significantly increase the risk of major CA. The pooled results yielded risk ratio (RR) for CA was 1.13 [95% CI (0.74, 1.73), p = 0.56, I2 = 0%]. Montelukast may be associated with preterm delivery and a low birthweight odds ratio (OR) of 1.82 [95% CI (1.35, 2.45), p < 0.001, I2 = 0%]. No significant risks were found concerning neurodevelopmental outcomes. The associations with spontaneous abortion were inconclusive [OR = 1.03, 95% CI (0.72, 1.5), p = 0.86, I2 = 73%], highlighting the need for further research. This comprehensive review underscores the importance of further investigating the safety profile of montelukast during pregnancy. While the overall findings indicate a relatively favorable safety profile, especially regarding major CA, careful consideration is needed for the potential risks of preterm delivery and low birthweight.

本系统综述和荟萃分析评估了孟鲁司特治疗妊娠期哮喘的安全性,重点关注孕产妇和胎儿的结局,如先天性畸形(CA)、早产、低出生体重、自然流产、妊娠糖尿病和子痫前期。我们在谷歌学术、PubMed 和 Cochrane 图书馆数据库中进行了全面的文献检索,检索时间从开始到 2024 年 4 月 30 日。符合条件的研究评估了孟鲁司特用于孕期哮喘治疗的安全性。综述表明,妊娠期使用孟鲁司特可能不会显著增加主要哮喘的风险。汇总结果显示,CA 的风险比 (RR) 为 1.13 [95% CI (0.74, 1.73),P = 0.56,I2 = 0%]。孟鲁司特可能与早产有关,低出生体重几率比(OR)为 1.82 [95% CI (1.35, 2.45),P 2 = 0%]。在神经发育结果方面没有发现明显的风险。与自然流产的相关性尚无定论[OR = 1.03,95% CI (0.72,1.5),p = 0.86,I2 = 73%],强调了进一步研究的必要性。本综合综述强调了进一步研究妊娠期孟鲁司特安全性的重要性。虽然总体研究结果表明该药的安全性相对较好,尤其是在主要的 CA 方面,但仍需谨慎考虑早产和低出生体重的潜在风险。
{"title":"Montelukast use in pregnancy: A systematic review and meta-analysis of maternal and fetal outcomes in asthma treatment","authors":"Areeba Fareed,&nbsp;Dima Siblini,&nbsp;Rayyan Vaid,&nbsp;Hadi Farhat,&nbsp;Ahmad Rida,&nbsp;Abdulrahmon Moradeyo,&nbsp;Muhammad Ahsan Khan","doi":"10.1111/cga.12581","DOIUrl":"10.1111/cga.12581","url":null,"abstract":"<p>This systematic review and meta-analysis evaluated the safety of montelukast in treating asthma during pregnancy, focusing on maternal and fetal outcomes such as congenital anomalies (CA), preterm delivery, low birthweight, spontaneous abortion, gestational diabetes mellitus, and preeclampsia. A comprehensive literature search was conducted in Google Scholar, PubMed, and the Cochrane Library databases from inception until April 30, 2024. The eligible studies assessed the safety of montelukast for asthma treatment during pregnancy. The review suggests that montelukast use during pregnancy may not significantly increase the risk of major CA. The pooled results yielded risk ratio (RR) for CA was 1.13 [95% CI (0.74, 1.73), <i>p</i> = 0.56, <i>I</i><sup>2</sup> = 0%]. Montelukast may be associated with preterm delivery and a low birthweight odds ratio (OR) of 1.82 [95% CI (1.35, 2.45), <i>p</i> &lt; 0.001, <i>I</i><sup>2</sup> = 0%]. No significant risks were found concerning neurodevelopmental outcomes. The associations with spontaneous abortion were inconclusive [OR = 1.03, 95% CI (0.72, 1.5), <i>p</i> = 0.86, <i>I</i><sup>2</sup> = 73%], highlighting the need for further research. This comprehensive review underscores the importance of further investigating the safety profile of montelukast during pregnancy. While the overall findings indicate a relatively favorable safety profile, especially regarding major CA, careful consideration is needed for the potential risks of preterm delivery and low birthweight.</p>","PeriodicalId":10626,"journal":{"name":"Congenital Anomalies","volume":"64 6","pages":"220-227"},"PeriodicalIF":1.3,"publicationDate":"2024-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141918346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A safety signal for congenital strabismus associated with valproic acid: A pharmacovigilance analysis utilizing the FDA Adverse Event Reporting System database 与丙戊酸相关的先天性斜视安全信号:利用 FDA 不良事件报告系统数据库进行药物警戒分析。
IF 1.3 4区 医学 Q3 PEDIATRICS Pub Date : 2024-07-31 DOI: 10.1111/cga.12579
Yuichi Uwai, Tomohiro Nabekura

This pharmacovigilance study investigated the relationship between antiepileptic drugs and congenital strabismus, utilizing the FDA Adverse Event Report System database between 2014 and 2023. Out of 28 347 889 reports of adverse events in 10 937 764 cases, we identified 1104 reports of strabismus and 67 of congenital strabismus. Valproic acid was the most frequently implicated primary suspect drug (95 and 14 cases, respectively). Ninety-five reports involved transplacental valproic acid exposure, yielding an information component (IC) of 7.06 (IC-2 × standard deviation: 5.50). A multivariate analysis showed that transplacental exposure to valproic acid correlated with strabismus (adjusted odds ratio: 8.47, 95% CI: 6.74–10.65). We revealed a robust safety signal linking valproic acid to congenital strabismus.

这项药物警戒研究利用 2014 年至 2023 年间美国食品药品管理局不良事件报告系统数据库,调查了抗癫痫药物与先天性斜视之间的关系。在 10 937 764 个病例的 28 347 889 份不良事件报告中,我们发现了 1104 份斜视报告和 67 份先天性斜视报告。丙戊酸是最常见的主要可疑药物(分别为 95 例和 14 例)。95例报告涉及经胎盘接触丙戊酸,信息成分(IC)为7.06(IC-2 × 标准差:5.50)。多变量分析显示,经胎盘接触丙戊酸与斜视有关(调整后的几率比:8.47,95% CI:6.74-10.65)。我们揭示了丙戊酸与先天性斜视相关的一个强有力的安全信号。
{"title":"A safety signal for congenital strabismus associated with valproic acid: A pharmacovigilance analysis utilizing the FDA Adverse Event Reporting System database","authors":"Yuichi Uwai,&nbsp;Tomohiro Nabekura","doi":"10.1111/cga.12579","DOIUrl":"10.1111/cga.12579","url":null,"abstract":"<p>This pharmacovigilance study investigated the relationship between antiepileptic drugs and congenital strabismus, utilizing the FDA Adverse Event Report System database between 2014 and 2023. Out of 28 347 889 reports of adverse events in 10 937 764 cases, we identified 1104 reports of strabismus and 67 of congenital strabismus. Valproic acid was the most frequently implicated primary suspect drug (95 and 14 cases, respectively). Ninety-five reports involved transplacental valproic acid exposure, yielding an information component (IC) of 7.06 (IC-2 × standard deviation: 5.50). A multivariate analysis showed that transplacental exposure to valproic acid correlated with strabismus (adjusted odds ratio: 8.47, 95% CI: 6.74–10.65). We revealed a robust safety signal linking valproic acid to congenital strabismus.</p>","PeriodicalId":10626,"journal":{"name":"Congenital Anomalies","volume":"64 5","pages":"207-214"},"PeriodicalIF":1.3,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141857420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Congenital Anomalies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1